Telephone booster contact for Cancer

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, OH
CancerTelephone booster contact - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether different forms of education and support can help caregivers of cancer patients feel better prepared.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Resuscitation Personnel
1
Clear Mask
1
Booster Training with the Neonatal Resuscitation Quality Improvement Cart

Study Objectives

1 Primary · 11 Secondary · Reporting Duration: at baseline, at end of treatment (average of seven weeks), and at 4 and 20 weeks post treatment

20 weeks post treatment
Anxiety
4 weeks post treatment
CG anxiety at 4 weeks post treatment
At end of treatment, average of seven weeks
CG anxiety at the end of radiation treatment
Interrupted treatment
Week 20
CG HRQOL as measured by PROMIS Global Health Scale Global Physical Health and Global Mental Health domains
CG depression
CG fatigue
Healthcare utilization cost
Participant HRQOL (cancer patient) as measured by FACT - E
Participant HRQOL (cancer patient) as measured by FACT-C
Participant HRQOL (cancer patient) as measured by FACT-H&N
Participant HRQOL (cancer patient) as measured by FACT-L

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Resuscitation Personnel
1
Clear Mask
1
Booster Training with the Neonatal Resuscitation Quality Improvement Cart

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control - Standard of Care
1 of 2
Intervention
1 of 2

Active Control

Experimental Treatment

180 Total Participants · 2 Treatment Groups

Primary Treatment: Telephone booster contact · No Placebo Group · N/A

InterventionExperimental Group · 2 Interventions: Telephone booster contact, One-on-one teaching sessions · Intervention Types: Behavioral, Behavioral
Control - Standard of CareNoIntervention Group · 1 Intervention: Control - Standard of Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at baseline, at end of treatment (average of seven weeks), and at 4 and 20 weeks post treatment

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
433 Previous Clinical Trials
30,425 Total Patients Enrolled
Susan Mazanec, PhDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are about to start your first round of radiation treatment.
You are a family member or friend of an adult patient who meets the criteria mentioned above.
References

Frequently Asked Questions

How many research participants are enrolled in this experiment?

"Yes, according to clinicaltrials.gov this study is actively searching for its required 180 participants from a single site. Noteworthy, the trial was first announced on December 17th 2019 and last updated November 14th 2022." - Anonymous Online Contributor

Unverified Answer

Is this research endeavor currently seeking participants?

"Affirmative. The clinical trial database at clinicaltrials.gov states that the study, which was initially announced on December 17th 2019, is actively recruiting for 180 participants from a single location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top